Hummingbird Diagnostics logo

Hummingbird Diagnostics

ID: 7024353

Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.

2

Funding Rounds

$14.2m

Money raised

Overview

Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Hummingbird Diagnostics has raised a total of $11.21m in funding over 2 rounds.

Key Insights:

  • Hummingbird Diagnostics Series A round, 2020: $8.2m
  • Hummingbird Diagnostics Venture round, Oct 2018: $3.01m

Industries

Hummingbird Diagnostics is active in the following industries: